Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission
Keith Humphreys, Chelsea L. Shover, Christina M. Andrews, et al.
The Lancet (2022) Vol. 399, Iss. 10324, pp. 555-604
Open Access | Times Cited: 303

Showing 1-25 of 303 citing articles:

Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial
Caitlin Jones, Richard O. Day, Bart W. Koes, et al.
The Lancet (2023) Vol. 402, Iss. 10398, pp. 304-312
Open Access | Times Cited: 92
Racial and Ethnic Disparities in Drug Overdose Deaths in the US During the COVID-19 Pandemic
Beth Han, Emily B. Einstein, Christopher M. Jones, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2232314-e2232314
Open Access | Times Cited: 76
Fentanyl-driven acceleration of racial, gender and geographical disparities in drug overdose deaths in the United States
Maria R. D’Orsogna, Lucas Böttcher, Tom Chou
PLOS Global Public Health (2023) Vol. 3, Iss. 3, pp. e0000769-e0000769
Open Access | Times Cited: 45
Hydrogel-Coated SERS Microneedles for Drug Monitoring in Dermal Interstitial Fluid
Li Yan, Yunqing Wang, Rongchao Mei, et al.
ACS Sensors (2024) Vol. 9, Iss. 5, pp. 2567-2574
Closed Access | Times Cited: 16
Understanding and Addressing Widening Racial Inequalities in Drug Overdose
Joseph Friedman, Max Jordan Nguemeni Tiako, Helena Hansen
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 381-390
Closed Access | Times Cited: 15
Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis
Erin J. Stringfellow, Tse Yang Lim, Keith Humphreys, et al.
Science Advances (2022) Vol. 8, Iss. 25
Open Access | Times Cited: 43
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review
Lauren A. Spreen, Emma N. Dittmar, Kyle Quirk, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2022) Vol. 42, Iss. 5, pp. 411-427
Open Access | Times Cited: 41
Racial and Ethnic Disparities in Opioid Access and Urine Drug Screening Among Older Patients With Poor-Prognosis Cancer Near the End of Life
Andrea C. Enzinger, Kaushik Ghosh, Nancy L. Keating, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 14, pp. 2511-2522
Open Access | Times Cited: 38
US drug overdose mortality rose faster among hispanics than non-hispanics from 2010 to 2021
Ruby Romero, Joseph Friedman, David Goodman‐Meza, et al.
Drug and Alcohol Dependence (2023) Vol. 246, pp. 109859-109859
Open Access | Times Cited: 24
Transitions in care between hospital and community settings for individuals with a substance use disorder: A systematic review
Hannah James, Jeffrey Morgan, Lianping Ti, et al.
Drug and Alcohol Dependence (2023) Vol. 243, pp. 109763-109763
Closed Access | Times Cited: 21
A multi-ancestry genetic study of pain intensity in 598,339 veterans
Sylvanus Toikumo, Rachel Vickers‐Smith, Zeal Jinwala, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 1075-1084
Open Access | Times Cited: 13
Sex dependence of opioid-mediated responses to subanesthetic ketamine in rats
Tommaso Di Ianni, Sedona N. Ewbank, Marjorie R. Levinstein, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis
Indhu Rammohan, Tommi Gaines, Ayden I. Scheim, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 2, pp. e79-e87
Open Access | Times Cited: 11
Thick Market Externalities and the Persistence of the Opioid Epidemic
David Cutler, J. Travis Donahoe
(2024)
Open Access | Times Cited: 10
Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021
Christopher M. Jones, Kun Zhang, Beth Han, et al.
JAMA Psychiatry (2024) Vol. 81, Iss. 8, pp. 789-789
Closed Access | Times Cited: 10
Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: a mortality data analysis from 2019 to 2022
Anne Hébert, Alison L. Hill
The Lancet Regional Health - Americas (2024) Vol. 36, pp. 100813-100813
Open Access | Times Cited: 10
Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials
Haron M. Jeddi, Jason W. Busse, Behnam Sadeghirad, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e068182-e068182
Open Access | Times Cited: 8
Effectiveness of Policies for Addressing the US Opioid Epidemic: A Model-Based Analysis from the Stanford-Lancet Commission on the North American Opioid Crisis
Isabelle J. Rao, Keith Humphreys, Margaret L. Brandeau
The Lancet Regional Health - Americas (2021) Vol. 3, pp. 100031-100031
Open Access | Times Cited: 45
Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal
Matthew B. Pomrenze, Daniel F. Cardozo Pinto, Peter A. Neumann, et al.
Neuron (2022) Vol. 110, Iss. 24, pp. 4125-4143.e6
Open Access | Times Cited: 36
Twenty-Year Trends in Drug Overdose Fatalities Among Older Adults in the US
Keith Humphreys, Chelsea L. Shover
JAMA Psychiatry (2023) Vol. 80, Iss. 5, pp. 518-518
Open Access | Times Cited: 19
Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review
David T. Zhu
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 19
Impact of COVID-19 pandemic on chronic pain and opioid use in marginalized populations: A scoping review
Karen Choe, Eleanor Zinn, Kevin Lu, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 18
The Baltic and Nordic responses to the first Taliban poppy ban: Implications for Europe & synthetic opioids today
Jonathan P. Caulkins, Amund R. Tallaksen, Jirka Taylor, et al.
International Journal of Drug Policy (2024) Vol. 124, pp. 104314-104314
Open Access | Times Cited: 6
In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling
Meng-Hua M. Tsai, Li Chen, Michael H. Baumann, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 4, pp. 854-867
Closed Access | Times Cited: 5
Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study
Benjamin L. Jones, Michelle Geier, John Neuhaus, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top